These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8779674)

  • 1. Molecular barriers to xenotransplantation.
    Lawson JH; Platt JL
    Transplantation; 1996 Aug; 62(3):303-10. PubMed ID: 8779674
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic microangiopathy: the next big hurdle for xenotransplantation.
    O'Connell PJ
    J Am Soc Nephrol; 2005 Sep; 16(9):2529-30. PubMed ID: 16093447
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutralization of anti-alphaGalactosyl antibodies without immunosuppression prevents hyperacute rejection but not acute vascular rejection of pig organs transplanted into baboons.
    Manez R; Crespo F; Gonzalez E; Centeno A; Juffe A; Arnal F; Cozzi E; White DJ; Duthaler R; Kinzy W; Oehrlein R; Katopodis A
    Transplant Proc; 2000 Aug; 32(5):888-9. PubMed ID: 10936260
    [No Abstract]   [Full Text] [Related]  

  • 4. Endothelial cell activation and thromboregulation during xenograft rejection.
    Bach FH; Robson SC; Ferran C; Winkler H; Millan MT; Stuhlmeier KM; Vanhove B; Blakely ML; van der Werf WJ; Hofer E; de Martin R; Hancock WW
    Immunol Rev; 1994 Oct; 141():5-30. PubMed ID: 7868157
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of cytokines in rejection of discordant xenotransplants.
    Saadi S; Takahashi T; Nagayasu T; Holzknecht RA; Platt JL
    Transplant Proc; 1999; 31(1-2):911-2. PubMed ID: 10083400
    [No Abstract]   [Full Text] [Related]  

  • 6. Gal alpha(1,3)Gal expression on neonatal porcine islet cells and susceptibility to human antibody/complement lysis.
    Rayat GR; Rajotte RV; Elliott JF; Korbutt GS
    Transplant Proc; 1998 Mar; 30(2):325. PubMed ID: 9532061
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral rejection and endothelial cell activation, 2001.
    Saadi S; Platt JL
    Xenotransplantation; 2002 Jul; 9(4):239-41. PubMed ID: 12060459
    [No Abstract]   [Full Text] [Related]  

  • 8. Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation.
    Miyagawa S; Matsunami K; Yoshitatsu M; Mikata S; Matsuda H; Shirakura R
    J Card Surg; 2001; 16(6):429-38. PubMed ID: 11925023
    [No Abstract]   [Full Text] [Related]  

  • 9. Xenotransplantation: endothelial cell activation and beyond.
    Bach FH; Robson SC; Ferran C; Millan M; Anrather J; Kopp C; Lesnikoski B; Goodman DJ; Hancock WW; Wrighton C
    Transplant Proc; 1995 Feb; 27(1):77-9. PubMed ID: 7879178
    [No Abstract]   [Full Text] [Related]  

  • 10. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice.
    McKenzie IF; Li YQ; Patton K; Thall AD; Sandrin MS
    Transplantation; 1998 Sep; 66(6):754-63. PubMed ID: 9771839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Xenotransplantation in man. 1: Immunology of xenogenic graft rejection].
    Borie DC; Poynard T; Hannoun L
    Gastroenterol Clin Biol; 1996; 20(11):972-81. PubMed ID: 9119187
    [No Abstract]   [Full Text] [Related]  

  • 12. Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation.
    Parker W; Holzknecht ZE; Song A; Blocher BA; Bustos M; Reissner KJ; Everett ML; Platt JL
    Am J Pathol; 1998 Mar; 152(3):829-39. PubMed ID: 9502425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical considerations in clinical cardiac xenografting.
    Pierson RN; White DJ; Wallwork J
    J Heart Lung Transplant; 1993; 12(5):876-8. PubMed ID: 7694655
    [No Abstract]   [Full Text] [Related]  

  • 14. Xenograft rejection--molecular mechanisms and therapeutic implications.
    Magee JC; Platt JL
    Ther Immunol; 1994 Jan; 1(1):45-58. PubMed ID: 7584479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on digestion of Gal alpha (1,3) Gal on porcine vascular endothelial cells by alpha-galactosidase].
    Wen J; Luo Y; Shen W
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):123-5. PubMed ID: 12212036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection.
    Xu H; Yin D; Naziruddin B; Chen L; Stark A; Wei Y; Lei Y; Shen J; Logan JS; Byrne GW; Chong AS
    J Immunol; 2003 Feb; 170(3):1531-9. PubMed ID: 12538718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenotransplantation: problems and approaches.
    Millan MT; Ferran C; Winkler H; Blakely ML; van der Werf WJ; Hancock WW; Bach FH
    Transplant Proc; 1994 Dec; 26(6):3593-6. PubMed ID: 7998285
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelial cell proteoglycans in xenotransplantation.
    Platt JL; Dalmasso AP; Vercellotti GM; Lindman BJ; Turman MA; Bach FH
    Transplant Proc; 1990 Jun; 22(3):1066. PubMed ID: 2349664
    [No Abstract]   [Full Text] [Related]  

  • 19. Discordant xenografting: a summary and look to the future.
    Bach FH
    Transplant Proc; 1992 Apr; 24(2):739-42. PubMed ID: 1566503
    [No Abstract]   [Full Text] [Related]  

  • 20. alphaGAL ligation with a lectin induces activation and resistance to the proinflammatory effects of human complement on porcine endothelium.
    Grehan JF; Kulick DM; Guzman-Paz M; Bolman RM; Dalmasso AP
    Transplant Proc; 2000 Aug; 32(5):975. PubMed ID: 10936307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.